Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of Canagliflozin on function of CD34+ve endothelial progenitor cells (EPC) in patients with type 2 diabetes.

Cardiovascular diabetology - 13 Feb 2021

Nandula Seshagiri Rao, Kundu Nabanita, Awal Hassan B, Brichacek Beda, Fakhri Mona, Aimalla Nikhila, Elzarki Adrian, Amdur Richard L, Sen Sabyasachi

Abstract excerpt

BACKGROUND: Endothelial progenitor cells (EPCs) has been shown to be dysfunctional in both type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD) leading to poor regeneration of endothelium and renal perfusion. EPCs have been shown to be a robust cardiovascular disease (CVD) risk indicator. Effect of sodium glucose channel inhibitors (SGLT2i) such as Canagliflozin (CG) on a cellular biomarker such as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD34
Share to Chemotaxis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Double-Blind Method

Share to Endothelial Progenitor Cells

Share to Exosomes

Share to Glycated Hemoglobin

Share to Metformin

Share to Pilot Projects

Source

Open in PubMed Open full text

Identifiers

PMID: 33581737
DOI: 10.1186/s12933-021-01235-4
PMCID: PMC7881606

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of Canagliflozin on function of CD34+ve endothelial progenitor cells (EPC) in patients with type 2 diabetes.PMID 33581737Read ↗

Role of Canagliflozin on function of CD34+ endothelial progenitor cells (EPC) in patients with type 2 diabetesSemantic proximity Read ↗

Linagliptin, when compared to placebo, improves CD34+ve Endothelial Progenitor Cells in Type 2 diabetes subjects with chronic kidney disease taking metformin and/or insulin, a randomized controlled trial.Semantic proximity Read ↗

Metformin improves circulating endothelial cells and endothelial progenitor cells in type 1 diabetes: MERIT study.Semantic proximity Read ↗

Endothelial Progenitor Cell Dysfunction in Type 1 Diabetes: Another Consequence of Oxidative Stress?Semantic proximity Read ↗

Dapagliflozin restores diabetes-associated decline in vasculogenic capacity of endothelial progenitor cells via activating AMPK-mediated inhibition of inflammation and oxidative stressSemantic proximity Read ↗

Acute Effects of Linagliptin on Progenitor Cells, Monocyte Phenotypes, and Soluble Mediators in Type 2 Diabetes.Semantic proximity Read ↗

Quercetin targets VCAM1 to prevent diabetic cerebrovascular endothelial cell injurySemantic proximity Read ↗

Human Endothelial Progenitor Cells From Type II Diabetics Exhibit Impaired Proliferation, Adhesion, and Incorporation Into Vascular StructuresSemantic proximity Read ↗

Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes.Semantic proximity Read ↗

High glucose-induced endothelial progenitor cell dysfunction.Semantic proximity Read ↗

Metformin improves the angiogenic potential of human CD34⁺ cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction.Semantic proximity Read ↗

New immunophenotype of circulating endothelial progenitor cells and endothelial microparticles in patients with erectile dysfunction and metabolic syndrome: effects of tadalafil administration.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.